Puma Biotechnology

Puma pounces on failed Takeda drug, snapping up cancer prospect for knockdown price
Fierce Biotech
Wed, 09/21/22 - 10:17 am
Puma Biotechnology
Takeda
Aurora A/angiogenic kinase inhibitor
clinical trials
Alisertib
Final Highlights from the 2021 J.P. Morgan Healthcare Conference
BioSpace
Sat, 01/16/21 - 11:57 pm
JPMHC 2021
intravenous immunoglobulin
IDEAYA Biosciences
Jounce Therapeutics
Puma Biotechnology
Why Clovis Oncology, Immunomedics, and Puma Biotechnology All Spiked Today
Motley Fool
Tue, 04/21/20 - 12:07 am
Clovis Oncology
Immunomedics
Puma Biotechnology
cancer
Will Puma Biotechnology Break Out of Its Rut in 2020?
Motley Fool
Fri, 02/28/20 - 11:54 pm
Puma Biotechnology
Nerlynx
Xeloda
Puma Biotech’s Nerlynx remains a dud. Will a breast cancer expansion turn things around?
Fierce Pharma
Fri, 02/21/20 - 11:38 pm
Puma Biotechnology
Nerlynx
breast cancer
Puma Biotechnology Has a Simple Plan to Get Back to Growth
Motley Fool
Mon, 11/18/19 - 10:21 am
Puma Biotechnology
Nerlynx
breast cancer
Here's Why Puma Biotechnology Fell 24.1% in July
Motley Fool
Wed, 08/7/19 - 11:51 pm
Puma Biotechnology
earnings
Breast cancer survival data buoys Macrogenics and Puma
Biopharma Dive
Thu, 05/16/19 - 11:28 pm
Macrogenics
margetuximab
Puma Biotechnology
Nerlynx
breast cancer
ASCO 2019
Puma Biotech’s new cancer drug Nerlynx suffered a terrible quarter. What gives?
Fierce Pharma
Fri, 05/10/19 - 05:57 pm
Puma Biotechnology
Nerlynx
drug launches
Here's Why Puma Biotechnology Tumbled on Monday
Motley Fool
Mon, 04/1/19 - 09:28 pm
Puma Biotechnology
Nerlynx
3 Takeaways from Puma Biotechnology's 2018 Earnings
Motley Fool
Mon, 03/4/19 - 07:37 pm
Puma Biotechnology
earnings
3 Beaten-Down Biotech Stocks That Could Bounce Back in 2019
Motley Fool
Wed, 12/12/18 - 09:59 am
TG Therapeutics
Madrigal Pharmaceuticals
Puma Biotechnology
Here's Why Puma Biotechnology Tanked 37.3% in November
Motley Fool
Fri, 12/7/18 - 10:46 am
Puma Biotechnology
Nerlynx
breast cancer
Drug Approvals for the 2 Most Common Types of Cancer in the Last 2 Years
BioSpace
Mon, 11/19/18 - 11:29 am
cancer
breast cancer
lung cancer
drug approvals
AstraZeneca
Takeda
Ariad Pharmaceuticals
Merck
Pfizer
Novartis
Boehringer Ingelheim
Bristol-Myers Squibb
Eli Lilly
Puma Biotechnology
Mylan
Genentech
CHMP reverses course on neratinib, handing Puma an unexpected win on European marketing vote — shares soar
Endpoints
Tue, 06/26/18 - 11:58 am
Puma Biotechnology
Europe
CHMP
EMA
neratinib
Nerlynx
breast cancer
Ex-Puma exec sentenced to prison stretch on insider-trading conviction — ‘greed’ made me do it
Endpoints
Thu, 06/21/18 - 09:53 am
insider trading
Puma Biotechnology
Puma shares plummet as results from key trial delayed
Biopharma Dive
Sat, 05/12/18 - 01:42 pm
Puma Biotechnology
earnings
Nerlynx
clinical trials
Why Puma Biotechnology Shares Jumped 15% Friday
Motley Fool
Sat, 03/3/18 - 10:41 am
Puma Biotechnology
earnings
Nerlynx
breast cancer
Watch These February Biotech Catalysts
Seeking Alpha
Thu, 02/1/18 - 09:58 am
biotech
Dynavax
HEPLISAV-B
vaccines
Novavax
NanoFlu
Nerlynx
Puma Biotechnology
breast cancer
Puma Biotechnology shares tank after CHMP looks ready to hit a red light on neratinib
Endpoints
Wed, 01/24/18 - 09:13 am
Puma Biotechnology
CHMP
neratinib
cancer
Europe

Pages